【新版医疗器械GMP大家谈】鼓励数智化转型 打造提质新锚点

Core Viewpoint - The newly revised Medical Device Good Manufacturing Practice (GMP) aims to enhance the quality management of medical device production in China, encouraging a shift towards data-driven innovation and smart manufacturing in the industry [1][2]. Group 1: Overview of the New GMP - The revised GMP, effective from November 2025, includes 15 chapters and 132 articles, reflecting the current state and characteristics of China's medical device industry while incorporating international regulatory experiences [1]. - The new regulations emphasize the importance of digital transformation in the medical device sector, guiding companies towards high-quality development characterized by "smart manufacturing" [2]. Group 2: Trends in Smart Manufacturing - The integration of smart technologies such as IoT, big data, and AI is driving the medical device industry towards higher quality and greater intelligence [3]. - Key areas of impact include: - Innovation in R&D: Technologies like AI and simulation can enhance product performance and accelerate technological iterations [4]. - Production Efficiency: Smart manufacturing creates integrated digital platforms that synchronize information across various departments, improving production efficiency [4]. - Quality Control: Advanced sensors and automated testing can provide real-time quality data, shifting quality management from reactive to proactive [5]. Group 3: Data Management and Application - The new GMP outlines comprehensive data management requirements across the entire medical device production chain, ensuring traceability and control [6]. - Specific regulations include: - Information System Management: Companies must implement secure hardware and software environments to prevent external interference [7]. - Electronic Records Management: Companies are required to ensure the accuracy and traceability of electronic records, with strict user access controls [8]. Group 4: Challenges and Recommendations for Companies - The transition to smart manufacturing presents challenges such as high investment costs and a shortage of skilled personnel [9]. - Recommendations for companies include: - Building integrated digital management platforms and gradually expanding their application [9]. - Cultivating technical talent through training and awareness programs [9]. - Establishing a robust infrastructure for smart manufacturing, including data security measures [9]. Group 5: Regulatory Adaptation - The new GMP also calls for an upgrade in regulatory personnel's capabilities and methods, shifting from static to dynamic oversight [10]. - Key focus areas for regulators include: - Ensuring personnel have the necessary technical skills for smart manufacturing [10]. - Verifying the integrity and reliability of information systems [10]. - Establishing comprehensive network security strategies to protect data [10]. Group 6: Future Outlook - The new GMP signifies a significant step towards intelligent regulation in the medical device sector, with both companies and regulatory bodies needing to adapt to emerging trends [11][12].